Pharma Equity Group A/S (CPH:PEG)

Denmark flag Denmark · Delayed Price · Currency is DKK
0.1270
-0.0030 (-2.31%)
Jul 4, 2025, 2:30 PM CET
-54.80%
Market Cap 155.90M
Revenue (ttm) n/a
Net Income (ttm) -24.42M
Shares Out 1.23B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 537,110
Average Volume 1,189,855
Open 0.1255
Previous Close 0.1300
Day's Range 0.1215 - 0.1280
52-Week Range 0.0706 - 0.3200
Beta 0.89
RSI 60.08
Earnings Date Aug 14, 2025

About Pharma Equity Group

Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement. Its products under development that are in Phase II clinical trials include RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of Ulcus Cruris chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouch... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Denmark
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol PEG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.